News
HOLX
--
0.00%
--
Raymond James Maintains Outperform on Hologic, Raises Price Target to $88
Raymond James analyst Andrew Cooper maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $78 to $88.
Benzinga · 5h ago
Histology and Cytology Market - Detailed analysis of current industry figures with growth opportunities and forecasts growth by 2027
The global size is expected to reach USD 36.81 billion by 2027.
Heraldkeepers · 6h ago
Global Clinical Microbiology Market demand with COVID-19 recovery analysis 2021 | better delivery process to boost market growth by 2025
The is estimated to be USD 3.8 billion in 2020 and projected to reach USD 5.4 billion by 2025, at a CAGR of 6.6%.
Heraldkeepers · 10h ago
Pillar Biosciences Appoints Dr. Eric Lai to its Board of Directors
Pillar Biosciences, an innovative next-generation sequencing (NGS) solutions in-vitro diagnostics (IVD) company, today announced the appointment of Eric Lai, Ph.D. to the Board of Directors. Dr. Lai brings more than 20 years of experience in drug and IVD m...
Business Wire · 1d ago
3D Mammography Systems Market Report 2021-2028 | Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast
Fortune Business Insights predicts the global 3D mammography systems market to grow at a robust speed in the coming years on account of rising prevalence of breast cancer worldwide. Key insights into the 3D mammography systems market is provided in a repor...
GlobeNewswire · 4d ago
Hologic Inc. stock rises Thursday, outperforms market
marketwatch.com · 4d ago
Hologic's (HOLX) Q3 Earnings Top Estimates, Q4 View Dull
Impressive performance by the Breast Health and GYN Surgical segments drive Hologic's (HOLX) fiscal third-quarter revenues.
Zacks · 5d ago
Fluid Management System Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2028
The global size is expected to reach USD 25.5 billion by 2028 according to a new study by . Worldwide Fluid Management System Market Analysis, 2021 research report portrays a profound plunge of market investigation and measurements of Global Fluid Managem...
Heraldkeepers · 5d ago
Research Alert: CFRA Maintains Buy Opinion On Shares Of Hologic, Inc.
MT Newswires · 5d ago
Hologic (HOLX) Q3 Earnings and Revenues Top Estimates
Hologic (HOLX) delivered earnings and revenue surprises of 19.82% and 12.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 5d ago
Hologic Q3 net income jumps 95% on significant YoY revenue increase
Hologic (NASDAQ:HOLX) saw its Q3 2021 net income jump 95% to $268.4M ($1.04 per diluted share) due to a surge in revenue. In the quarter, the company had revenue of
Seekingalpha · 5d ago
Hologic Inc. stock falls Wednesday, underperforms market
marketwatch.com · 5d ago
Recap: Hologic Q3 Earnings
Shares of Hologic (NASDAQ:HOLX) increased after the company reported Q3 results. Quarterly Results Earnings per share were up 77.33% year over year to $1.33, which beat the estimate of $1.12.
Benzinga · 5d ago
BRIEF-Hologic Announces Q3 Revenue $1.168 bln
reuters.com · 5d ago
Hologic EPS beats by $0.21, beats on revenue
Hologic (NASDAQ:HOLX): Q3 Non-GAAP EPS of $1.33 beats by $0.21; GAAP EPS of $1.04 beats by $0.14. Revenue of $1.17B (+42.2% Y/Y) beats by $130M. FQ4 2021 guidance: Revenue: $1,000 -
Seekingalpha · 5d ago
Hologic Announces Financial Results for Third Quarter of Fiscal 2021
MARLBOROUGH, Mass., July 28, 2021--Hologic Announces Financial Results for Third Quarter of Fiscal 2021
Business Wire · 5d ago
Hologic Q3 Gains Top Street Views, Q4 EPS Outlook Short as COVID-19 Testing Revenue Wanes
MT Newswires · 6d ago
-- Earnings Flash (HOLX) HOLOGIC Reports Q3 EPS $1.33, vs. Street Est of $1.12
MT Newswires · 6d ago
-- Earnings Flash (HOLX) HOLOGIC Posts Q3 Revenue $1.17B, vs. Street Est of $1.039B
MT Newswires · 6d ago
-- GUIDANCE: (HOLX) HOLOGIC Forecasts Q4 EPS Range $0.92 - $1.00
MT Newswires · 6d ago
Webull provides a variety of real-time HOLX stock news. You can receive the latest news about Hologic through multiple platforms. This information may help you make smarter investment decisions.
About HOLX
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.